Sophia Genetics is a health technology company which develops SOPHiA artificial intelligence for clinical genomics used by healthcare institutions worldwide. The Company offers DRY LAB, an analytical solution for treating raw next-generation DNA sequencing (NGS) data; BUNDLE that offers enrichment kit and access to SOPHiA DDM platform; and integrated diagnostic solutions. It also provides SOPHiA DDM, a software-as-a-service platform that enables analysis and protection of clinical NGS data in the areas of oncology, metabolism, pediatrics, cardiology, and hereditary cancer.
Sophia Genetics total Funding
Sophia Genetics latest funding size
Time since last funding
|22 days ago|
Sophia Genetics investors
|Balderton Capital, ACE & Company, Idinvest Partners, Swisscom Ventures, 360 Capital Partners, Generation Investment Management, Endeavour Vision, Invoke Capital Partners, Marc Coucke, Alychlo, aMoon Ventures, Eurazeo Growth, Hitachi Ventures, Famille C Invest|
Sophia Genetics has 21.39k Twitter Followers. The number of followers has increased 0.2% month over month and increased 0.2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Sophia Genetics founded?
Sophia Genetics was founded in 2011.
Who are Sophia Genetics key executives?
Sophia Genetics's key executives are Jurgi Camblong, Damien Lapray and Valentin Matillon.
How many employees does Sophia Genetics have?
Sophia Genetics has 362 employees.
Who are Sophia Genetics competitors?
Competitors of Sophia Genetics include HistoGeneX, Ablacon and Therapixel.
Where is Sophia Genetics headquarters?
Sophia Genetics headquarters is located at 172 Rue du Centre, Saint-Sulpice.
Where are Sophia Genetics offices?
Sophia Genetics has offices in Saint-Sulpice, Boston, Bidart and Cambridgeshire.
How many offices does Sophia Genetics have?
Sophia Genetics has 4 offices.
Receive alerts for 300+ data fields across thousands of companies